FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns antineutrophilic agent representing 4-bromine-6-[3-(4-chlorophenyl)propoxy]-5-(3-pyridylmethylamino)-3(2H)-pyridasinone or its pharmaceutically acceptable salt, effective for treating chronic obstructive respiratory disease.
EFFECT: agent ensures improved therapeutic effectiveness.
3 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREVENTER OF BLOOD VESSELS INTIMA HYPERPLASIA | 2005 |
|
RU2339381C2 |
| THERAPEUTIC AGENT FOR TREATMENT OF SPINAL CHANNEL STENOSIS | 1999 |
|
RU2229297C2 |
| DERIVATIVES OF 3(2H)-PYRIDAZINONE AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION ON THEIR BASE | 1991 |
|
RU2054004C1 |
| AGENT FOR TREATMENT OF ERECTILE FUNCTION | 1999 |
|
RU2229885C2 |
| DERIVATIVES OF 3(2H)-PYRIDAZINONES OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2138486C1 |
| MULTIKINASE INHIBITOR COMPOUND AND ITS CRYSTALLINE FORM AND USE | 2017 |
|
RU2723985C1 |
| PYRIDAZINONE DERIVATIVES AND METHODS OR PREPARING THEREOF | 1996 |
|
RU2131419C1 |
| BENZOXAZINE DERIVATIVES AND THEIR APPLICATION | 2004 |
|
RU2354651C2 |
| DERIVATIVES OF PYRIDAZINONE AND TRIAZINONE AND THEIR USING AS PHARMACEUTICAL PREPARATIONS | 2001 |
|
RU2279428C2 |
| HETEROARYL[4,3-c]PYRIMIDINE-5-AMINE DERIVATIVE, ITS PREPARATION METHOD AND ITS MEDICAL APPLICATIONS | 2018 |
|
RU2764655C2 |
